Xiaoyan Wang

6PUBLICATIONS
12CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersOther agricultural, veterinary and food sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 03, 2026
Differential [18F]FAPI-42 and [18F]FDG uptake patterns distinguish desmoid tumours from GISTs on PET/CT imaging.

Chunhui Wu, Xiaoyan Wang, Xiaojie Lin

|Nov 21, 2025
Induction chemotherapy plus camrelizumab followed by concurrent chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma: a single-arm phase II trial.

Fang Peng, Jialiang Wu, Huimin Lian

|Oct 15, 2025
18F-FDG PET/CT and contrast-enhanced CT evaluation of lymph node status after neoadjuvant immunochemotherapy in patients with esophageal squamous cell carcinoma.

Yuhong Wang, Xin Hu, Tianhong Yang

|Aug 15, 2024
Predictive performance of [18F]F-fibroblast activation protein inhibitor (FAPI)-42 positron emission tomography/computed tomography (PET/CT) in evaluating response of recurrent or metastatic gastrointestinal stromal tumors: complementary or alternative to [18F]fluorodeoxyglucose (FDG) PET/CT?

Chunhui Wu, Fang Wen, Fangzeng Lin

|Sep 15, 2022
Correction to: [18F]FAPI‑42 PET/CT versus [18F]FDG PET/CT for imaging of recurrent or metastatic gastrointestinal stromal tumors.

Chunhui Wu, Xinhua Zhang, Yu Zeng

|Aug 30, 2022
[18F]FAPI-42 PET/CT versus [18F]FDG PET/CT for imaging of recurrent or metastatic gastrointestinal stromal tumors.

Chunhui Wu, Xinhua Zhang, Yu Zeng

Pageof 1

Frequent Collaborators

2 joint publications

Chao Cheng

1 joint publications

Fang Peng

1 joint publications

Jialiang Wu

1 joint publications

Shuang Wu